We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
-8.36%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$128K
AUM Growth
-$145M
Cap. Flow
-$18.7M
Cap. Flow %
-14,564.08%
Top 10 Hldgs %
50.52%
Holding
100
New
14
Increased
2
Reduced
4
Closed
34

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$3.37M
2
RPD icon
Rapid7
RPD
+$3.15M
3
DEN
Denbury Inc.
DEN
+$2.29M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$1.6M
5
AJRD
Aerojet Rocketdyne Holdings
AJRD
+$1.27M

Top Sells

Rank Stock Value
1
HHLA
HH&L Acquisition Co.
HHLA
+$16.7M
2
OSH
Oak Street Health, Inc.
OSH
+$8.12M
3
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$6.64M
4
NATI
National Instruments Corp
NATI
+$4.61M
5
SHUA
SHUAA Partners Acquisition Corp I Class A Ordinary Share
SHUA
+$2.88M

Sector Composition

Rank Sector Weight
1 Healthcare 12.27%
2 Financials 11.94%
3 Technology 5.54%
4 Materials 2.71%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LATGW
51
DELISTED
LatAmGrowth SPAC Warrants
LATGW
$400 0.31%
37,499
– –
JGGCW
52
DELISTED
Jaguar Global Growth Corporation I Warrant
JGGCW
$397 0.31%
37,499
– –
CCVI.WS
53
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$350 0.27%
33,999
– –
SCRMW
54
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$344 0.27%
33,331
– –
COCHW icon
55
Envoy Medical Warrant
COCHW
$425K
$342 0.27%
33,332
– –
ALVOW icon
56
Alvotech Warrant
ALVOW
$45.3M
$335 0.26%
43,287
– –
FRXB.WS
57
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$289 0.23%
28,199
– –
ASBPW
58
Aspire Biopharma Warrant
ASBPW
$264 0.21%
24,999
– –
KYCHW
59
DELISTED
Keyarch Acquisition Corporation Warrant
KYCHW
$209 0.16%
19,998
– –
LSBPW
60
DELISTED
LakeShore Biopharma Warrants
LSBPW
$207 0.16%
149,999
– –
AAC.WS
61
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$169 0.13%
15,999
– –
BBAI.WS icon
62
BigBear.ai Holdings Warrant
BBAI.WS
$38.4M
$157 0.12%
66,665
– –
SDSTW
63
Stardust Power Inc Warrant
SDSTW
$4.93M
$142 0.11%
13,333
– –
PIIIW icon
64
P3 Health Partners Inc Warrant
PIIIW
$130K
$130 0.1%
43,334
– –
JGGCR
65
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$11 0.01%
75,000
– –
KYCHR
66
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$6 ﹤0.01%
40,000
– –
ACI icon
67
Albertsons Companies
ACI
$5.62B
– –
-30,000
Closed -$623K
FHN icon
68
CALL
First Horizon
FHN
$12.2B
– –
-242,800
Closed -$4.32M
FHN icon
69
First Horizon
FHN
$12.2B
– –
-20,000
Closed -$356K
MTAL
70
DELISTED
Metals Acquisition
MTAL
– –
-24,900
Closed -$254K
NRG icon
71
CALL
NRG Energy
NRG
$28.3B
– –
-75,000
Closed -$2.57M
TSEM icon
72
Tower Semiconductor
TSEM
$24.8B
– –
-60,000
Closed -$2.48M
ASBP
73
Aspire Biopharma
ASBP
$8.44M
– –
-42
Closed -$525K
SPWRW
74
SunPower Inc Warrants
SPWRW
$538K
– –
-33,265
Closed -$343K
LATG
75
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
– –
-75,000
Closed -$785K
1 2
3
4

Similar funds

THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
FAL
Focused Alpha LLC Denver, Colorado $324M AUM
AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return
KL
Knox Lane San Francisco, California $325M AUM
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
MFA
Morling Financial Advisors Fremont, California $325M AUM 21.97% 1-Year Est. Return

Athos Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Athos Capital held 100 positions worth $128K, down 100% from $145M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Athos Capital withdrew a net $18.7M in Q2 2023, closing 34 positions and reducing 4 holdings. Its most notable exit was HH&L Acquisition Co., an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

Against the trend, Athos Capital opened a new position in Globus Medical worth $3.52K.

  • Athos Capital's largest Q2 2023 buy was Globus Medical: 59,200 shares worth $3.52K.
  • Athos Capital added most to Aerojet Rocketdyne Holdings in Q2 2023, an estimated $1.27M increase.
  • Athos Capital's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $1.31M.
  • Athos Capital fully exited HH&L Acquisition Co. in Q2 2023, selling an estimated $16.7M.
  • Athos Capital's ten largest holdings make up 51% of its $128K portfolio in Q2 2023.
  • Athos Capital opened 14 new positions and closed 34 in Q2 2023.
  • Athos Capital's portfolio value fell 100% quarter-over-quarter to $128K.

Based on Athos Capital's 13F filing for Q2 2023, filed 14 Aug 2023.